Bispecific antibodies offer transformative potential but add CMC complexity versus mAbs. We present a modular, bioinformatics-guided platform integrating ApolloX™ cell line development, automated high-throughput (HTP) screening with a pre-optimized elution strategy, and orthogonal analytics. Predict-first triage directs candidates to standard or targeted upstream /downstream modules, shortening development, improving quality, and accelerating IND/GMP readiness.
Primary Interest(Required)
Segments(Required)
Sub-Segments(Required)
Privacy Policy(Required)
By submitting this form I agree that FUJIFILM Biotechnologies may process my data in the manner described in FUJIFILM’s Privacy Policy